Free shipping on all orders over $ 500

Proton Pump Proton Pump

Cat.No.  Name Information
M5728 Lansoprazole Lansoprazole is a proton-pump inhibitor (PPI) which prevents the stomach from producing gastric acid.
M4953 Bafilomycin A1 Bafilomycin A1 (BafA1) is a vacuolar H+-ATPase inhibitor with IC50 of 0.44 nM.
M55502 Esomeprazole-d3 sodium Esomeprazole-d3 sodium
M20547 Rabeprazole Related Compound E Rabeprazole Related Compound E is the active metabolite of Rabeprazole and an orally active proton pump inhibitor that inhibits gastric acid secretion by interacting with (H+/K+)-ATPase in gastric lining cells. In addition, Rabeprazole Related Compound E significantly inhibits the activity of Helicobacter pylori and can be used in studies related to various digestive disorders.
M20514 Omeprazole Sodium Omeprazole Sodium is the sodium salt form of omeprazole, which is a proton pump inhibitor and suppresses gastric acid secretion.
M20434 Rabeprazole Rabeprazole is an orally active proton pump inhibitor that inhibits gastric acid secretion by interacting with (H+/K+)-ATPase in gastric lining cells. In addition, Rabeprazole significantly inhibits the activity of Helicobacter pylori and may be used in studies related to various digestive disorders.
M5633 Pantoprazole sodium Pantoprazole is a proton pump inhibitor drug that inhibits gastric acid secretion. It works on gastric parietal cells to irreversibly inhibit (H+/K+)-ATPase function and suppress the production of gastric acid.
M5285 Ilaprazole Ilaprazole, a substituted benzimidazole, is a new candidate drug that is an H+ /K+ ATPase inhibitor designed for the treatment of gastric ulcers.
M3707 Rabeprazole Sodium Rabeprazole is a frequently used second-generation proton pump inhibitor (PPI) that irreversibly inactivates gastric H+/K+-ATPase.
M3575 Esomeprazole Magnesium Esomeprazole Magnesium is a proton pump inhibitor to reduce gastric acid secretion.
M3448 Esomeprazole Sodium Esomeprazole Sodium is a sodium salt of esomeprazole that is a potent proton pump inhibitor with an IC50 of 0.076 mg/kg.
M3056 Tenatoprazole Tenatoprazole is a procompound of the proton pump inhibitor (PPI) class, which inhibits proton transport with IC50 of 3.2 μM.
M2627 Dexlansoprazole Dexlansoprazole, the dextrorotatory enantiomer of lansoprazole, is a proton pump inhibitor (PPI) formulated to have dual delayed-release properties.
M1834 Omeprazole (H 16868) Omeprazol is a first-in-class proton pump inhibitor (PPI) used in the treatment of dyspepsia, laryngopharyngeal reflux (LPR) and Zollinger–Ellison syndrome.
M56565 Lansoprazole sulfone Lansoprazole sulfone (AG-1813) is an orally active and selective inhibitor of H+, K+-ATPase.
M52724 Caloxin 2A1 Caloxin 2A1 is an extracellular plasma membrane Ca2+-ATPase (PMCA) peptide inhibitor.
M42247 CS-526 CS-526 is a potent, selective, reversible and orally active acid pump antagonist.
M29085 Revaprazan Revaprazan (SB 641257) is a reversible proton pump inhibitor with significant anti-inflammatory effects. Revaprazan can be used for chronic gastric inflammation research.
M29058 Vonoprazan hydrochloride Vonoprazan hydrochloride, a proton pump inhibitor (PPI), is a potent and orally active potassium-competitive acid blocker (P-CAB), with antisecretory activity. Vonoprazan hydrochloride inhibits H+,K+-ATPase activity in porcine gastric microsomes with an IC50 of 19 nM at pH 6.5.
M29008 Abeprazan hydrochloride Abeprazan hydrochloride (DWP14012 hydrochloride) is a potassium-competitive acid blocker. Abeprazan hydrochloride inhibits H+, K+- ATPase by reversible potassium-competitive ionic binding with no acid activation required. Abeprazan hydrochloride is developed as a potential alternative to proton pump inhibitor for the treatment of acid-related diseases.




Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.